Salivary Biomarkers for Concussion
Determination of the Physiological Profile and Evaluation of the Effect of Intense Physical Exertion Among Professional Athletes
Sys2Diag
80 participants
Dec 12, 2023
OBSERVATIONAL
Conditions
Summary
Concussion (CC) (also called mild head trauma), which accounts for 85% of all head injuries, is very common in professional and amateur athletes. CC is an injury to the brain resulting from the direct or indirect impact of external mechanical forces, momentarily disrupting its function on a cellular level. Unlike more serious head injury (moderate and severe), which can be diagnosed using neuroimaging techniques (CT, MRI, etc.), patients suffering from CC do not necessarily show visible signs of structural abnormalities. As a result, diagnosis of CC is offen difficult. Recently, several salivary biomarkers (proteins and nucleic acids) of sport related concussion have been identified in professional athletes. However, their reference values have not been determined with sufficient robustness to enable their employment in concussion diagnostic tests.
Eligibility
Inclusion Criteria12
- Male participants aged between 18 and 50 years old.
- Participants willing to comply with the study procedures.
- Participants capable of understanding the purpose, nature, and methodology of the study.
- Participants affiliated to a French social security system or beneficiaries of such a system.
- Participants who have signed the non-opposition form to participate in the research.
- Participant not affiliated to a French social security system or not a beneficiary of such a system.
- Participants deprived of liberty, protected adults, vulnerable individuals, or minors.
- Participants with a proven or suspected chronic infectious disease that may introduce a risk of contamination during sample handling (laboratories not equipped to handle this type of sample).
- Refusal to sign the non-opposition form to participate in the research.
- Non-inclusion specific criteria
- Subject who has had a recent stroke or epilepsy event (within the past two months).
- Subject suffering from neurological diseases.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Saliva of participants will be sampled for analysis of biomarkers of interest (nucleic acids and proteins). The nucleic acids biomarkers will be quantified by reverse transcription followed by amplification (RT-PCR) and Next Generation Sequencing (NGS) techniques while enzymatic assay methods (ELISA) methods will be used to quantify protein biomarkers.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06149351